Your browser doesn't support javascript.
loading
First Lung Transplantation in Jehovah's Witness Patient in Latin America.
Fernandez-Trujillo, Liliana; Sanabria, Fernando; Bautista, Diego F; Velazquez, Mauricio; Cujiño, Indira; Tafur, Eric; Arboleda, Daniel; Zuñiga-Restrepo, Valeria; Martinez, Willian.
Afiliação
  • Fernandez-Trujillo L; Department of Internal Medicine, Pulmonology Service, Interventional Pulmonology, Fundación Valle del Lili, Cali, Colombia.
  • Sanabria F; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
  • Bautista DF; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
  • Velazquez M; Department of Internal Medicine, Pulmonology Service, Fundación Valle del Lili, Cali, Colombia.
  • Cujiño I; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
  • Tafur E; Department of Critical Care Medicine, Fundación Valle del Lili, Cali, Colombia.
  • Arboleda D; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
  • Zuñiga-Restrepo V; Department of Surgery, Thoracic Surgery Service, Fundación Valle del Lili, Cali, Colombia.
  • Martinez W; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
Clin Med Insights Case Rep ; 13: 1179547620940737, 2020.
Article em En | MEDLINE | ID: mdl-32733126
Lung transplantation is a life-saving alternative for patients with end-stage lung disease. The procedure itself has a high risk of bleeding. Jehovah's Witness patients refuse to accept blood products due to religious beliefs. A 48-year-old Jehovah's Witness woman presented with an 8-year history of cough, dyspnea along with progressive worsening of her functional class and quality of life. A diagnosis of autoimmune interstitial lung disease was made, for which cyclophosphamide was administered without improvement of symptoms, and the patient was accepted as a transplant candidate. Transplantation was performed without complications, nor blood products requirement, intraoperative cell salvage was performed, and pharmacological agents were used preoperatively for bleeding prevention. The patient only developed anemia after administration of immunosuppressor therapy, which was treated with erythropoietin in the outpatient setting.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article